Eve & Co Incorporated (V:EVE)
Business Focus: Alternative Medicine
| Sector: Healthcare | Industry: Pharmaceuticals |
| Company Contact | |
| Address: | 2941 Napperton Drive STRATHROY ON N7G3H8 |
| Tel: | N/A |
| Website: | https://www.evecannabis.ca |
| IR: | See website |
| Key People | ||
| Melinda Rombouts President, Chief Executive Officer, Director | Rory Taylor Interim Chief Financial Officer | Ivan Ross Vrana Vice President - Governmental Relations and Business Development |
| Business Overview |
| Eve & Co Incorporated is a Canada-based company, which holds cultivation and processing licenses for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil. It is a licensed producer of medicinal marijuana. It also provides educational information and online support for its customers and first-time buyers. Its products include The Boss Bath Bomb, The Dreamer Bath Bomb, The Lover Bath Bomb, The Optimist CBD Bath Bomb, Indica Blend, Sativa Blend, The Boss, The Confidant, The Creator, The Lover, The Adventurer, The Advocate, and The Free Spirit. Its wholly owned subsidiary is Natural MedCo Ltd. The Boss Bath Bomb has an invigorating blend of sweet orange, lemon, and grapefruit essential oils that come together to enhance and lift mood, reduce stress, and stimulate circulation. The Dreamer Bath Bomb has calming lavender and chamomile essential oils that help to reduce stress and anxiety and promote calmness. |
| Financial Overview |
| For the nine months ended 30 September 2021, Eve & Co Inc revenues increased from C$2.6M to C$6.5M. Net loss decreased 65% to C$2.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Stock-Based Compensation decrease from C$1.3M (expense) to C$80K (income), Professional Fees decrease of 50% to C$421K (expense). |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $23.63M as of Sep 30, 2021 |
| Annual revenue (TTM): | $7.77M as of Sep 30, 2021 |
| EBITDA (TTM): | -$3.22M as of Sep 30, 2021 |
| Net annual income (TTM): | -$5.92M as of Sep 30, 2021 |
| Free cash flow (TTM): | -$0.87M as of Sep 30, 2021 |
| Net Debt Last Fiscal Year: | $19.92M as of Sep 30, 2021 |
| Shares outstanding: | 36,754,098 as of Feb 24, 2022 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
